BofA Securities Downgrades Cara Therapeutics (CARA) to Underperform

March 7, 2023 4:48 PM EST Send to a Friend
BofA Securities analyst Jason Gerberry downgraded Cara Therapeutics (NASDAQ: CARA) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login